1. Home
  2. ARTL vs TC Comparison

ARTL vs TC Comparison

Compare ARTL & TC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • TC
  • Stock Information
  • Founded
  • ARTL 2011
  • TC 2010
  • Country
  • ARTL United States
  • TC China
  • Employees
  • ARTL N/A
  • TC N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • TC Business Services
  • Sector
  • ARTL Health Care
  • TC Consumer Discretionary
  • Exchange
  • ARTL Nasdaq
  • TC Nasdaq
  • Market Cap
  • ARTL 3.1M
  • TC 2.5M
  • IPO Year
  • ARTL N/A
  • TC 2018
  • Fundamental
  • Price
  • ARTL $9.76
  • TC N/A
  • Analyst Decision
  • ARTL Buy
  • TC
  • Analyst Count
  • ARTL 2
  • TC 0
  • Target Price
  • ARTL $30.00
  • TC N/A
  • AVG Volume (30 Days)
  • ARTL 1.4M
  • TC 191.7K
  • Earning Date
  • ARTL 08-12-2025
  • TC 08-29-2025
  • Dividend Yield
  • ARTL N/A
  • TC N/A
  • EPS Growth
  • ARTL N/A
  • TC N/A
  • EPS
  • ARTL N/A
  • TC N/A
  • Revenue
  • ARTL N/A
  • TC $6,737,269.00
  • Revenue This Year
  • ARTL N/A
  • TC N/A
  • Revenue Next Year
  • ARTL N/A
  • TC N/A
  • P/E Ratio
  • ARTL N/A
  • TC N/A
  • Revenue Growth
  • ARTL N/A
  • TC N/A
  • 52 Week Low
  • ARTL $4.92
  • TC $0.46
  • 52 Week High
  • ARTL $25.58
  • TC $4.30
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 60.38
  • TC 46.55
  • Support Level
  • ARTL $9.11
  • TC $0.75
  • Resistance Level
  • ARTL $13.22
  • TC $0.89
  • Average True Range (ATR)
  • ARTL 1.83
  • TC 0.06
  • MACD
  • ARTL 0.47
  • TC -0.01
  • Stochastic Oscillator
  • ARTL 21.64
  • TC 13.40

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About TC TuanChe Limited

Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.

Share on Social Networks: